针对TLR4:一个有前途的治疗方法跨越多种人类疾病
Sakshi Kumar1, Vikram Sharma1, Shikha Yadav2
1Department of Pharmacy, Galgotias College, Greater Noida, Uttar Pradesh, 201310, India.
Current protein & peptide science
|December 26, 2024
概括
收费类受体4 (TLR4) 对于免疫力至关重要,并与代谢障碍,神经退行和癌症等非传染性疾病有关. 准TLR4通过调节炎症和恢复免疫平衡,为各种疾病提供了一个有希望的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 收费类受体4 (TLR4) 是天生的免疫系统的关键组成部分,识别病原体相关的分子模式和内源性连接体.
- 除了在感染中的作用外,TLR4越来越多地被认为与非传染性疾病有关,包括代谢障碍,神经退行性疾病和癌症.
研究的目的:
- 探索TLR4信号在各种人类疾病中的多方面的作用.
- 突出针对各种病理状态的TLR4通路的治疗潜力.
主要方法:
- 关于TLR4信号在疾病发病过程中的当前科学文献的综述.
- 对针对TLR4的新兴治疗策略的分析,包括药理学药物,饮食干预和微生物群调节.
主要成果:
- 失调的TLR4激活有助于在代谢障碍 (肥胖,糖尿病),心血管疾病,神经退行性疾病 (阿尔茨海默氏症,帕金森氏症) 和癌症中的炎症和疾病进展.
- 目前正在开发针对TLR4的各种药理学药物,如小分子抑制剂和单克隆抗体.
- 饮食干预和微生物群操纵正在成为TLR4调节的额外策略.
结论:
- 针对TLR4信号传递,为广泛的人类疾病提供了一个有前途的治疗途径.
- 调节TLR4可以帮助控制炎症,恢复免疫平衡,并可能阻止疾病的进展.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
115
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
115
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.


